ArticleBMC cancer2020

Survival impact of extended cycles of second-line chemotherapy in platinum-sensitive relapsed ovarian cancer patients with residual tumor after six cycles.

Se Ik Kim et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.